Lynda Szczech, MD
Intercept Pharmaceuticals
4
0
1
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
E.J.L (Jenny) Heathcote, MD
UHN - Toronto Western Hospital, University of Toronto
Shared therapeutic areas:
Rong Deng
Cascade Pharmaceuticals, Inc
Shared therapeutic areas:
Jason Sluzevich, MD
Mayo Clinic
Shared therapeutic areas:
Andrew L Mason, MBBS MRCPI
University of Alberta
Shared therapeutic areas:
Andrew Mason, MD
University of Alberta
Shared therapeutic areas:
John Magee, MD
University of Michigan Medical Center, Ann Arbor
Shared therapeutic areas:
Fu-Sheng Wang, professor
Beijing 302 Hospital
Shared therapeutic areas:
Aldo Torre Delgadillo, M.D. M.Sc
INCMNSZ
Shared therapeutic areas:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Fengchun Zhang, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
Obeticholic Acid in Pediatric Subjects With Biliary Atresia
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
All 4 trials loaded